The store will not work correctly when cookies are disabled.
3,3-dimethyl-1-(5-(2-methyl-1H-imidazol-1-yl)pyrazin-2-yl)-6-(2-methylpyrimidin-5-yl)indolin-2-one
ID: ALA4203736
PubChem CID: 129126865
Max Phase: Preclinical
Molecular Formula: C23H21N7O
Molecular Weight: 411.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ncc(-c2ccc3c(c2)N(c2cnc(-n4ccnc4C)cn2)C(=O)C3(C)C)cn1
Standard InChI: InChI=1S/C23H21N7O/c1-14-25-10-17(11-26-14)16-5-6-18-19(9-16)30(22(31)23(18,3)4)21-13-27-20(12-28-21)29-8-7-24-15(29)2/h5-13H,1-4H3
Standard InChI Key: PBZHRILHADNSNO-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 35 0 0 0 0 0 0 0 0999 V2000
16.6286 -10.2108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6327 -11.0280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3384 -10.6158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4398 -11.2921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4386 -12.1116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1467 -12.5206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1449 -10.8832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7325 -12.5199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0248 -12.1090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3173 -12.5164 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3162 -13.3345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0285 -13.7435 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7332 -13.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8535 -11.2885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8583 -12.1116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6427 -12.3614 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1227 -11.6926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9399 -11.6874 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6276 -13.1788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9109 -13.5737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8955 -14.3900 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5961 -14.8123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6087 -13.7434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3255 -13.5975 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3094 -14.4079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5894 -15.6315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9219 -16.1030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1641 -16.8835 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.9812 -16.8944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2440 -16.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1482 -15.8401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 15 2 0
14 7 2 0
7 4 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
5 8 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 2 1 0
2 14 1 0
17 18 2 0
19 20 2 0
20 21 1 0
21 22 2 0
22 25 1 0
24 19 1 0
16 19 1 0
11 23 1 0
24 25 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 26 1 0
22 26 1 0
27 31 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 411.47 | Molecular Weight (Monoisotopic): 411.1808 | AlogP: 3.69 | #Rotatable Bonds: 3 |
Polar Surface Area: 89.69 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.40 | CX LogP: 2.72 | CX LogD: 2.68 |
Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.51 | Np Likeness Score: -0.94 |